TrademarkDir
(KV) KALIVIR IMMUNOTHERAPEUTICS
LIVE

Serial Number

97150675

Owner

KALIVIR IMMUNOTHERAPEUTICS, INC.

Attorney

DRAEKE H. WESEMAN

Filing Date

Dec 1, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

(KV) KALIVIR IMMUNOTHERAPEUTICS Trademark

Serial Number: 97150675

(KV) KALIVIR IMMUNOTHERAPEUTICS is a trademark filed by KALIVIR IMMUNOTHERAPEUTICS, INC. on December 1, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

KALIVIR IMMUNOTHERAPEUTICS, INC. (9 trademarks)

240 Alpha Drive
Pittsburgh, PA 15238

Entity Type: 03

Trademark Details

Filing Date

December 1, 2021

Registration Date

Not Registered

Published for Opposition

November 12, 2024

Goods & Services

Biological preparations for use in immunotherapy, namely, oncolytic vaccinia viruses; Pharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith; Biopharmaceutical preparations for the treatment of treatment of cancer; Biopharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 24, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jun 23, 2026 EX3G
SOU EXTENSION 3 FILED
Jun 23, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 23, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 23, 2025 EXRA
SOU EXTENSION 2 GRANTED
Dec 23, 2025 EX2G
SOU EXTENSION 2 FILED
Dec 23, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 23, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jun 4, 2025 EX1G
SOU EXTENSION 1 FILED
Jun 4, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 4, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 24, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2024 NONP
EXPARTE APPEAL TERMINATED
Oct 2, 2024 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2024 CNSA
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 4, 2024 JURT
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 25, 2023 ERFR
EX PARTE APPEAL-INSTITUTED
Oct 25, 2023 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Oct 25, 2023 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Oct 25, 2023 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 21, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 21, 2023 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 27, 2023 GNFN
FINAL REFUSAL E-MAILED
Apr 27, 2023 GNFR
FINAL REFUSAL WRITTEN
Apr 27, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 20, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 19, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 19, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 19, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 10, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 7, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2021 NWOS
NEW APPLICATION ENTERED
Dec 4, 2021 NWAP

Related Trademarks

More from this Owner

TOMORROW'S TECHNOLOGY, TODAY'S CURE

TOMORROW'S TECHNOLOGY, TODAY'S CURE

TOMORROW'S TECHNOLOGY, TODAY'S CURE

TOMORROW'S TECHNOLOGY, TODAY'S CURE

MULTIPLE THERAPIES, ONE VIRUS

MULTIPLE THERAPIES, ONE VIRUS

MULTIPLE THERAPIES, ONE VIRUS

MULTIPLE THERAPIES, ONE VIRUS

(KV) KALIVIR IMMUNOTHERAPEUTICS logo

(KV) KALIVIR IMMUNOTHERAPEUTICS

MULTIPLE THERAPIES, ONE VIRUS

MULTIPLE THERAPIES, ONE VIRUS